Enrique F. Salido-Portillo

Logrono, LO 26004, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

New strategy for treating visceral pain: Enhancing opioid antinociception by Sigma-1 receptor inhibition.

New strategy for treating visceral pain: Enhancing opioid antinociception by Sigma-1 receptor inhibition.

Journal: The journal of pain

Published: January 29, 2026

New Strategy for Treating Visceral Pain: Enhancing Opioid Antinociception by Sigma-1 Receptor Inhibition.

New Strategy for Treating Visceral Pain: Enhancing Opioid Antinociception by Sigma-1 Receptor Inhibition.

Journal: The journal of pain

Published: January 29, 2026

Sigma-1 Receptors Control Neuropathic Pain and Peripheral Neuroinflammation After Nerve Injury in Female Mice: A Transcriptomic Study.

Sigma-1 Receptors Control Neuropathic Pain and Peripheral Neuroinflammation After Nerve Injury in Female Mice: A Transcriptomic Study.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: December 20, 2023

Resilience to Pain-Related Depression in σ1 Receptor Knockout Mice Is Associated with the Reversal of Pain-Induced Brain Changes in Affect-Related Genes.

Resilience to Pain-Related Depression in σ1 Receptor Knockout Mice Is Associated with the Reversal of Pain-Induced Brain Changes in Affect-Related Genes.

Journal: ACS chemical neuroscience

Published: September 22, 2023

Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ-1 Subunit of Voltage-Gated Calcium Channel and the μ-Opioid Receptor.

Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ-1 Subunit of Voltage-Gated Calcium Channel and the μ-Opioid Receptor.

Journal: ChemMedChem

Published: September 01, 2023

Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain: The Case of the Sigma-1 Receptor.

Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain: The Case of the Sigma-1 Receptor.

Journal: ACS pharmacology & translational science

Published: January 12, 2022

Administration of the sigma-1 receptor agonist PRE-084 at emerging adulthood, but not at early adolescence, attenuated ethanol-induced conditioned taste aversion in female rats.

Administration of the sigma-1 receptor agonist PRE-084 at emerging adulthood, but not at early adolescence, attenuated ethanol-induced conditioned taste aversion in female rats.

Journal: Neuroscience letters

Published: December 25, 2021

Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels.

Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels.

Journal: ACS medicinal chemistry letters

Published: July 29, 2021

Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain.

Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain.

Journal: Journal of medicinal chemistry

Published: July 08, 2021

Bicyclic Diazepinones as Dual Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels and the Norepinephrine Transporter.

Bicyclic Diazepinones as Dual Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels and the Norepinephrine Transporter.

Journal: Journal of medicinal chemistry

Published: February 16, 2021

Sigma-1 antagonism inhibits binge ethanol drinking at adolescence.

Sigma-1 antagonism inhibits binge ethanol drinking at adolescence.

Journal: Drug and alcohol dependence

Published: May 25, 2020

Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis.

Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis.

Journal: Frontiers in pharmacology

Published: February 27, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026